Leukeran and Itching - a phase IV clinical study of FDA data

Summary:

Itching is reported as a side effect among people who take Leukeran (chlorambucil), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Neupogen, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Itching when taking Leukeran. It is created by eHealthMe based on reports of 1,144 people who have side effects when taking Leukeran from the FDA, and is updated regularly.

What is Leukeran?

Leukeran has active ingredients of chlorambucil. eHealthMe is studying from 1,158 Leukeran users. Check the latest studies of Leukeran.

What is Itching?

Itching is found to be associated with 3,210 drugs and 4,534 conditions by eHealthMe. Check the latest studies of Itching.

On Jul, 14, 2026

1,144 people reported to have side effects when taking Leukeran.
Among them, 27 people (2.36%) have Itching.

Among these 27 people:

How long have people been on Leukeran when they have Itching? *

What is the gender of people who have Itching when taking Leukeran? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Itching when taking Leukeran? *

What are other drugs people take besides Leukeran? *

What are other side effects people have besides Itching? *

Rashes (redness): 14 people, 51.85%
Fever: 8 people, 29.63%
Weight Decreased: 7 people, 25.93%
Fatigue (feeling of tiredness): 7 people, 25.93%
Nausea And Vomiting: 7 people, 25.93%
Back Pain: 6 people, 22.22%
Nausea (feeling of having an urge to vomit): 6 people, 22.22%
Weakness: 6 people, 22.22%
Arrhythmias (irregular heartbeat): 5 people, 18.52%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 5 people, 18.52%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 7 people, 25.93%
Multiple Myeloma (cancer of the plasma cells): 4 people, 14.81%
Immunodeficiency Disorders: 4 people, 14.81%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 4 people, 14.81%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 7.41%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 3.70%
Fungal Infection: 1 person, 3.70%
Erysipelas (bacterial skin infection): 1 person, 3.70%
Breast Cancer Female: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Leukeran and have Itching?

- Check whether Itching is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Leukeran:

Leukeran (1,158 reports)

Itching treatments and more:

Itching (398,821 reports)

Browse all side effects of Leukeran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Itching:

Itching (3,210 drugs)

Browse all the conditions that are associated with Itching:

Itching (4,534 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on chlorambucil (the active ingredients of Leukeran) and Leukeran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.